Aromatase inhibitor (AI) treatment is first-line systemic treatment for the bulk of postmenopausal breasts malignancy individuals with estrogen receptor (Emergency room)-positive main tumor. Maintenance of Emergency room expression and function was a general finding, but ER reduction was seen in…